You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interleukin-2

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in United States (Entinostat, Interleukin-2)

Active, not recruiting
  • Renal Cell Carcinoma
  • Los Angeles, California
  • +4 more
Feb 14, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer Trial in Minneapolis (IP FT516, Enoblituzumab,

Completed
  • Ovarian Cancer
  • +2 more
  • IP FT516
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Apr 12, 2022

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • Human umbilical cord mesenchymal stem cells
  • Interleukin-2
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022

MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

Not yet recruiting
  • MSS
  • Rectal Cancer
  • Sintilimab with Interleukin-2
  • (no location specified)
Nov 1, 2023

Lymphocytes, Tumor-Infiltrating Trial in Saint Petersburg (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide,

Not yet recruiting
  • Lymphocytes
  • Tumor-Infiltrating
  • Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide, Interleukin-2
  • Saint Petersburg, Florida
  • +1 more
Sep 15, 2023

GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

Terminated
Has Results
  • Graft Versus Host Disease
  • Cyclophosphamide and Sirolimus
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022

Hematopoietic Stem Cell Transplantation Trial in Nantes (IL2, Zoledronic Acid)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • IL2
  • Zoledronic Acid
  • Nantes, France
    Nantes Uh
Mar 29, 2022

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Interleukin-2
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

HIV Trial run by the NIAID (Aldesleukin)

Completed
  • HIV Infections
  • Bethesda, Maryland
    Natl Inst of Allergy & Infect Dis / Cln Ctr
Oct 27, 2021

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Sentinel Lymph Node Biopsy (SLNB)
  • +7 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

Neuroblastoma Trial in Houston (SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP, SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2

Active, not recruiting
  • Neuroblastoma
  • SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 1 SKNLP
  • SNJB-JF-IL2 and SJNB-JF-Lptn + Dose Level 2 SKNLP
  • Houston, Texas
    Texas Children's Hospital
Mar 3, 2022

NHL, Multiple Myeloma, Blood Cancer Trial in Minneapolis, Houston, Fairfax (IDP-023, Rituximab, Daratumumab)

Recruiting
  • NHL
  • +6 more
  • Minneapolis, Minnesota
  • +2 more
Nov 7, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Scottsdale, Arizona
  • +4 more
Dec 27, 2022

Periodontal Disease Stage 2 Trial in Cairo (Non surgical periodontal therapy)

Recruiting
  • Periodontal Disease Stage 2
  • Non surgical periodontal therapy
  • Cairo, Egypt
    Faculty of Dentistry-Ain Shams University
Jul 25, 2023

Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Cytokine Induced Memory-like Natural Killer Cells
  • Interleukin-2
  • Boston, Massachusetts
  • +1 more
Nov 14, 2023

Breast Tumors Trial in Guangzhou (procedure, drug, biological)

Recruiting
  • Breast Neoplasms
  • Surgery for harvesting tumor-draining lymph nodes
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Nov 2, 2023

HIV Trial run by the NIAID (Interleukin-2)

Completed
  • HIV Infections
  • Interleukin-2
  • Bethesda, Maryland
    NIH Intramural Research Program ACTG CRS
Oct 28, 2021

Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

Recruiting
  • Solid Tumor
  • HPV-T
  • Interleukin-2
  • Wuhan, Hubei, China
    Wuhan Union Hospital
May 31, 2023

Metastatic Melanoma Trial in Tampa (procedure, drug, other)

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • Surgery
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023